1 |
Oriental medicine dictionary editing committee. Supplemental Oriental medicine dictionary, Seoul, Jeongdam, 1998:1354.
|
2 |
Kim JS. Standard Galenicalpharmacy, Seoul, Jinmyung publishing company, 1975:353.
|
3 |
Ouh ER. Bonchoujongshin, Seoul, Hanglimseswon, 1972:120.
|
4 |
Mun G et al. East & West Combine Treatment of Cancer II, Iksan, Wonkwang Univ, 1999:741-93.
|
5 |
Chung BS et al. Illustrated Herb dictionary, Seoul Youngrimsa, 1990:775-7.
|
6 |
Gae WB. Pharmacology & application of Anticancer Herb, Harbin, Hukrunggang Science technology publishing company, 1999:1200, 1268-9.
|
7 |
Oriental Herb dictionary editing committee. Supplemental Oriental Herb dictionary(8), Seoul, Jeongdam, 1997:3711-4.
|
8 |
Shin KG. Shinssi Hebal Medicine, Seoul, Sumunsa, 1982:160-1.
|
9 |
Lee SJ. Bonchougangmok, Beijing, Human Health publishing company, 1988:1987-91.
|
10 |
Shin MG. Clinical Galenicalpharmacy, Seoul, Youngrimsa, 1988:591-592.
|
11 |
Bang YJ. Practical Chinese internalmedicine, Shanghai, Shanghai science technology publishing company, 1986:12-6, 621-35.
|
12 |
Chai YM. New Pharmacology & application of Chinese Herb, Beijing, Hwaha publishing company, 1999:521.
|
13 |
Rae JK et al. Chinese Clinical Galenicalpharmacy(ha), Beijing, Human Health publishing company, 1998:1856-8.
|
14 |
Pathology Society of Korea. Pathology, Seoul, Komunsa, 1990:179-86.
|
15 |
Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.Cancer Res, 1993:53:3979-85.
|
16 |
Agarwal ML, Taylor WR, Chernov MV, Chernova OB, Stark GR. The p53 network. J. Biol. Chem. 1998:273:1-4.
DOI
|
17 |
Korean Health Organization. : Korean herb standard book, Seoul, 1984:111.
|
18 |
Martin SJ et al. Proteolysis of fodrin (nonerythroid spectrin) during apoptosis. J. Biol. Chem, 1995:270:6425-8.
|
19 |
Gangsou New medicine academy. Chinese Herb dictionary I(ha), Shanghai, Shanghai science technology publishing company, 1979:2587-9.
|
20 |
Tang W, Eisenbrand G. Chinese drugs of plant origin.Springer-Verlag, New York, 1992:51-7.
|
21 |
Alnemri ES et al. Human ICE/CED-3 protease nomenclature. Cell, 1996:87:171.
DOI
|
22 |
Hwang SG et al. Proteolysis of beta-catenin in apoptotic Jurkat cells. Journal of Life Science, 2000:10:57-63.
|
23 |
Bicknell GR, Snowden RT, Cohen GM. Formation of high molecular mass DNA fragments is a marker of apoptosis in the human leukemic cell line. U937. J. Cell Sci, 1994:107:2483-9.
|
24 |
Serrano M, Hannon GJ, Beach D. A new regulatory motif incell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 1993:366:704-7.
DOI
|
25 |
Grana X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclindependent kinase inhibitors (CKIs). Oncogene, 1995:11:211-19.
|
26 |
Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 nheterodimerizes in vivo with a conserved homolog, Bax, thataccelerates programmed cell death. Cell, 1993:74:609-619.
DOI
|
27 |
Driks PB, Rutka JT. Current concepts in neurooncology: thecell cycle. Neurosurgery, 1997:40: 1000-13.
DOI
|
28 |
Baek HR. Byunjeongshidhi outline, Unnam, Human publishing company, 1984:502.
|
29 |
Suffness M, Douros J. Current status of the NCI plant and animal product program. J. Nat. Prod, 1982:45:1-14.
DOI
|
30 |
Ashall F, Bramwell ME, Harris H. A new marker for humancancer cells. Lancet, 1982:2:1-6.
|
31 |
Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol, 1991:139:271-9.
|
32 |
Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification ofprogrammed cell death in situ via specific labeling of nuclear DNAfragmentation. J. Cell Bio, 1992:119:493-501.
DOI
|
33 |
Wang JY, Knudsen ES, Welch PJ. The retinoblastoma tumor suppressor protein. Adv. Cancer Res, 1994:64:25-85.
|
34 |
Ruddon RW. Chemical carcinogenesis. In principles of drug action (3rd.), Churchill Livingstone, 1999:735.
|
35 |
Son GW. Chinese Treatment of Leukemia, Hongkong, Haebong publishing company, 1990:112-3.
|
36 |
Moran P. Cellular effects of cancer chemotherapy administration. J. Intraven. Nurs, 2000:23:44-51.
|
37 |
Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell Biol, 1995:15:2612-24.
DOI
|
38 |
An WG, Hwang SG, Trepel JB, Blagosklonny MV. Protease inhibitor -induced apoptosis: accumulation wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers ofproteasome inhibition. Leukemia, 2000:14:1276-83.
DOI
|
39 |
School of Medicine Seoul national univ. Oncology, Seoul national univ publishing part, 1992:1-3, 78-90, 137-43, 225-34.
|